ScholarIQanswers from OpenAlex

Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease

PaperCitations, authors & open-access status

Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease have?

ScholarIQcitation count

Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease published?

ScholarIQyear

Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease has 2025 year in the ScholarIQ index.

What is the open-access status of Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease?

ScholarIQoa status

Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease has hybrid oa status in the ScholarIQ index.

What is the DOI of Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease?

ScholarIQdoi

The DOI for Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease is on the source record.

What is the PMID of Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease?

ScholarIQpmid

The PMID for Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease is on the source record.

What is the OpenAlex record for Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease?

ScholarIQopenalex

The OpenAlex for Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial